Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-04-20 @ 3:00 AM
Study NCT ID:
NCT03222856
Status:
COMPLETED
Last Update Posted:
2025-06-05
First Post:
2017-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes
Sponsor:
MedSIR
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-13
First Submit QC Date:
None
Study First Post Date:
2017-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-09
Results First Submit QC Date:
None
Results First Post Date:
2025-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-16
Last Update Post Date:
2025-06-05
Last Update Post Date Type:
ACTUAL